. Author manuscript; available in PMC: 2016 Sep 1.

Published in final edited form as: Eur Radiol. 2015 Mar 29;25(9):2665–2672. doi: 10.1007/s00330-015-3688-1

Table 4.

Associations between relative changes of tumour ADC (mm²/s) and K^trans (min^-1) and PSA nadirs during therapy and when including the complete follow-up.

Median (range), n	PSA nadir during therapy			PSA nadir including follow-up

	<0.05 ng/ml	Measurable PSA	Adjusted p Value	<0.05 ng/ml	Measurable PSA	Adjusted p Value
ADC	−0.25 (−0.69, 0.49), 13	−0.07 (−0.79, 0.08), 19	0.390	−0.17 (−0.69, 0.49), 21	−0.16 (−0.79, 0.08), 11	0.907
K^trans	0.54 (0.23, 0.86), 7	0.58 (0.06, 0.88), 11	0.724	0.52 (0.06, 0.86), 14	0.63 (0.32, 0.88), 4	0.763